Skip to content

Augmented-reality Based Mirror Therapy in Stroke Rehabilitation

Effects of Augmented-reality Based Mirror Therapy on Sensorimotor Function of Upper Extremity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05580744
Enrollment
48
Registered
2022-10-14
Start date
2023-01-03
Completion date
2024-05-27
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Rehabilitation, Technology, Mirror Movement Therapy

Brief summary

In the proposed study, the investigators assumed that mirror therapy combined with augmented reality technology will provide a better treatment effects than traditional mirror therapy for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either augmented reality based mirror therapy, mirror therapy or traditional occupational therapy on the upper extremity function and brain activity of the stroke patients.

Interventions

Motor training targeted to goals that are relevant to the functional needs of the patient

OTHERMirror therapy using a mirror box

Mirror therapy using a mirror box

OTHERAugmented reality-based mirror therapy

Augmented reality-based mirror therapy

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of stroke with unilateral side involved; * A score of Mini-mental state examination greater than 24 for proving higher mental function * Time of onset \> 6 months before treatment begins; and * Premorbid right-handedness.

Exclusion criteria

* Severe vision impairment; * Major cognitive-perceptual deficit; * Other brain disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity testbaseline, 9 weeks and 21 weeksEach item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

Secondary

MeasureTime frameDescription
Change in the result of Modified Ashworth scale (MAS)baseline, 9 weeks and 21 weeksMuscle tone is defined by the resistance of a muscle being stretched without resistance. The MAS scores were distributed across the entire scale, ranging from 0 to 4, that is convenient for the clinician use. The grading of the scale is described as below: 0) no increase in muscle tone; 1) minimal resistance at the end of the range of motion; 1+) slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the reminder (less than half) of the ROM; 2) more marked increase in tone but only after part is easily flexed; 3) considerable increase in tone; and 4) passive movement is difficult and affected part is rigid in flexion or extension.
Change in the result of Box and blocks testbaseline, 9 weeks and 21 weeksThe score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.
Change in the result of Semmes-Weinstein monofilament (SWM) testbaseline, 9 weeks and 21 weeksThe Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.
Change in the result of Motor Activity Logbaseline, 9 weeks and 21 weeksSemi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-5. Higher values represent a better outcome.

Other

MeasureTime frameDescription
changes in oxygenated (HbO) and deoxygenated (Hb) hemoglobin concentrations using near infrared spectroscopy (NIRS)baseline, 9 weeks and 21 weeksTo investigate the activation of specific brain regions

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026